EGFR and breast carcinoma: Cellular IF assay also showed that EYA2 overexpression (Figure 6A) enhanced the protein abundance of YBX1 (Figure 6B), EGFR (Figure 6C), and PCNA (Figure 6D) in both breast cancer cell lines.